Treosulfan Based Conditioning Followed by Allogeneic Hematopoietic Cell Transplantation for Treatment of Patients with Non-Malignant Diseases: Preliminary Results of a Phase II Study
Lauri M. Burroughs(Fred Hutch Cancer Center), Ann E. Woolfrey(University of Washington), K. Scott Baker(Malaria Consortium), Jennifer Domm(Vanderbilt University), Eneida R. Nemecek(Oregon Health & Science University), Akiko Shimamura(Harvard University), Katherine A. Guthrie, Janet A. Englund(Seattle Children's Hospital), Troy R. Torgerson(Allen Institute for Immunology), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Suzanne Skoda‐Smith(University of Washington), Julie‐An Talano(Dana-Farber Cancer Institute), Paul A. Carpenter(Fred Hutch Cancer Center)
Cited by 0
Related Papers
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k